• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Influenza Virus Vaccine for the 2010-2011 Season

Cumulative 2010/2011 Season Lot Release Status (Updated 3/30/2011)

Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers. For information on flu vaccine distribution schedules, please contact the manufacturers directly.

Vaccine & ManufacturerTotal number of Lots
Released by FDA
AFLURIA
CSL Limited

36*

Fluarix
GlaxoSmithKline Biologicals
18*
FluLaval
ID Biomedical Corp. of Quebec
37*
FluMist
MedImmune, LLC
33*
Agriflu
Novartis Vaccines and Diagnostics Incorporated
1
Fluvirin
Novartis Vaccines and Diagnostics Limited
57
Fluzone
Sanofi Pasteur, Inc.
145

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Bethesda, Maryland, on February 22, 2010, to select the influenza viruses for the composition of the influenza vaccine for the 2010-2011 U.S. influenza season.  During this meeting, the advisory committee reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics of recent influenza isolates, serological responses to 2009-2010 vaccines, and the availability of candidate strains and reagents.

The committee recommended that vaccines to be used in the 2010-2011 influenza season in the U.S. contain the following:

  • an A/California/7/09 (H1N1)-like virus; **
  • an A/Perth /16/2009 (H3N2)-like virus; ***
  • a B/Brisbane/60/2008-like virus.****

The influenza vaccine composition to be used in the 2010-2011 influenza season in the U.S. is identical to that recommended by the World Health Organization on February 18, 2010, for the Northern Hemisphere's 2010-2011 influenza season.

*Done for the season. 

**A/California/7/09 (H1N1)-like virus is the pandemic (H1N1) 2009 influenza virus.  A monovalent vaccine containing this strain was made available to the United States in the fall of 2009.

***A/Perth/16/2009 (H3N2)-like virus is a change from the 2009-2010 influenza vaccine formulation.

****and B/Brisbane /60/2008-like virus is a current vaccine virus.

 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002